Rottendorf Pharma
Dr. Klaus Schilling has a diverse work experience. Dr. Klaus started their career as a Tutor at Julius-Maximilians-Universität Würzburg in 2014. Dr. Klaus then worked as a Pharmazeut im Praktikum at the same university from 2015 to 2016. Following that, they gained further experience as a Pharmazeut im Praktikum at Schopp's Apotheke am Reckerpark from May 2016 to October 2016. Dr. Klaus returned to Julius-Maximilians-Universität Würzburg in 2016 to work as a Doktorand until April 2020. From February 2020 to May 2021, they worked at Kirsch Pharma HealthCare GmbH in various roles including Laborleiter / stellv. Leitung Qualitätsskontrolle. Most recently, they joined Rottendorf Pharma as the Head of Laboratories in July 2022.
Dr. Klaus Schilling's education history begins in 2011 when they started studying Pharmazie at The Julius Maximilians University of Würzburg. Dr. Klaus completed this degree in 2016, obtaining their 3. Staatsexamen and becoming an Apotheker. Dr. Klaus then pursued further education at the same university, earning a Dr. rer. nat. degree in Pharmazie from 2016 to 2020. Additionally, they obtained a Fachapotheker für Pharmazeutische Analytik degree from 2017 to 2020.
This person is not in the org chart
Rottendorf Pharma
1 followers
A first-class contract development and manufacturing organization (CDMO), Rottendorf Pharma has been manufacturing, packaging, developing formulations and analytical methods for solid oral dosage forms for the global pharmaceutical industry for more than 85 years. The company produces more than 600 originator and generic drug products annually for big, small, virtual, and global pharmaceutical and biotechnology companies. Rottendorf Pharma operates by the philosophy of Total Process Ownership (TPO) and Total Technological Mastering (TTM), in which we work as an extension of clients' organizations. Therefore leveraging our expertise to optimize solid dosage form production for our customers' benefit. Rottendorf Pharma has neither their own product brands in the market nor holds any product licenses, and therefore is never in competition with their clients.